EMJ Respiratory 10 [Supplement 2] 2022
The continued inclusion of oral corticosteroids (OCS) in treatment guidelines, as well as the accessibility, familiarity, and relatively low cost of this therapeutic option compared with newer alternatives, has contributed to an ongoing overreliance on OCS treatments in severe asthma. This overuse continues despite accumulating evidence to demonstrate the detrimental long-term effects associated with even a short-term, low-dose course of OCS in this patient population.
EMJ Microbiology & Infectious Diseases 3 [Supplement 2] 2022
Infectious disease experts Benoît Guery, Associate Professor of Infectious Diseases, University Hospital, Lausanne, Switzerland, and Javier Cobo Reinoso, Infectious Disease Consultant, Hospital Ramón y Cajal, Madrid, Spain, are featured in this article, which covers the challenges that practitioners, infectious disease experts, and hospital managers tackle in developing and implementing effective antimicrobial strategies that support better patient outcomes.
EMJ Respiratory 10 [Supplement 1] 2022
All human diseases, including COPD, are the end result of gene–environment interactions. However, this conventional model is being modified. COVID-19 demonstrated that mortality is higher in older versus younger individuals. The viral and environmental exposures were the same, but the obvious difference was age.
EMJ Gastroenterology 11.1 2022
Welcome to the latest issue of EMJ Gastroenterology, which outlines key advances in the field. Featured articles include a case report on medullary carcinoma of the pancreas and a review of the challenges in inflammatory bowel disease management during the COVID-19 pandemic in resource-limited settings. Our independent review of United European Gastroenterology (UEG) Week 2022 is also not to be missed!
EMJ Rheumatology 9 [Infographic 1] 2022
Osteoarthritis is the most common form of long-term musculoskeletal disease, and is increasing in prevalence as societies become older. One of the key factors of living well with a disease that spans decades of a patient’s life is to diagnose the condition earlier, long before the disease limits function significantly, or causes disability.
EMJ Oncology 10 [Supplement 11] 2022
This symposium review article features key learnings and updates in cutaneous lymphomas shared at the European Organisation for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Tumours Group (CLTG) Annual Meeting 2022, which took place in Madrid, Spain, between 22nd and 24th September. Presentations covered a broad range of topics in the field of cutaneous lymphomas, encompassing molecular mechanisms in cutaneous T cell lymphoma (CTCL), diagnostics, prediction of prognosis, and CTCL treatment.
EMJ Nephrology 10 [Infographic 2] 2022
This infographic explores the epidemiology, burden, and unmet need in IgA nephropathy (IgAN). Delving into the pathophysiology of IgAN, the infographic breaks down the different aspects of the kidney that are impacted by the inflammatory mediators endothelin-1 and angiotensin II.